netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US
No announcement available or all announcement expired.
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US

Orderly wind up of Wanda and Vortex

Mar 18, 2019
-
RNS Announcements

18 March 2019

NetScientific plc
(“NetScientific” or the “Company”)

Orderly wind up of Wanda and Vortex

 

Further to its announcement and circular to shareholders (“Circular”) on 15 February 2019, NetScientific plc (AIM: NSCI) announces that the directors of each of Vortex Biosciences (“Vortex”) and Wanda, Inc. (“Wanda”), which are Portfolio Companies of NetScientific,  have resolved to effect the orderly wind up of those respective companies.

In the Circular, NetScientific had stated that it would allocate the Company’s remaining cash to managing its stakes in those Portfolio Companies which the Board believed provided the most realistic prospects of delivering Shareholder returns within the anticipated lifespan of the Company. At that stage, the Board believed those Portfolio Companies would be Glycotest, Inc. (“Glycotest”), ProAxsis Ltd (“ProAxsis”) and PDS BioTechnology (“PDS”).  

Absent viable additional funding, the Board continues to believe that Glycotest, ProAxsis and PDS provide the most realistic prospects of delivering Shareholder returns within the anticipated lifespan of the Company. Accordingly, having reviewed and considered the cash position of the Company, and any potential additional funding options available to the Company, the Board resolved that it was not in a position to continue to provide financial support to Vortex and Wanda without prejudicing its ability to allocate sufficient cash resources to Glycotest, ProAxsis and PDS.

The Company has received an indicative proposal from a third party regarding the sale of the Company’s shareholdings in Wanda and Vortex (the “Potential Disposal”). Having considered the indicative terms of, and taking account of the anticipated timeline to complete and the execution risks of, the Potential Disposal, the Board believes that the level of consideration offered is not sufficient to justify the Company continuing to provide the necessary financial support to Wanda and Vortex whilst due diligence and negotiations regarding the terms of the Potential Disposal are undertaken, without prejudicing the Company’s ability to allocate sufficient cash resources to Glycotest, ProAxsis and PDS. The Board has therefore concluded that it was not in the best interests of the Company to proceed with the Potential Disposal.

Subsequently, the directors of Vortex and Wanda respectively resolved to effect the orderly wind up of those companies.

 

Capitalised terms used in this announcement have the meanings given to them in the Circular sent to Shareholders on 15 February 2019.

 

The Company anticipates releasing another announcement regarding another Portfolio Company shortly.

 

For more information, please contact:

NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO    

                   

Tel: +44 (0)20 3514 1800

WH Ireland Limited (NOMAD, Financial Adviser and Broker)

Chris Fielding / Jessica Cave

 

Tel: +44 (0)20 7220 1666

 

Consilium Strategic Communications            

Mary-Jane Elliott / Chris Welsh / Laura Thornton

NetScientific@consilium-comms.com

Tel: +44 (0)20 3709 5700

 

 

About NetScientific

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases.

For more information, please visit the website at http://www.NetScientific.net

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
PDS completes merger with Edge Therapeutics
NEXT POST →
Share Price Movement

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
copyright
Terms of Use
Orderly wind up of Wanda and Vortex - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.